20% Benzocaine And 3% Resorcinol Cream
Over-the-Counterالأسماء التجارية: Equate Vagicaine
About This Medication
Topical anesthetic cream combining benzocaine and resorcinol used to temporarily relieve pain, itching, and discomfort from minor skin conditions.
المواد الفعالة
| المادة الفعالة | التركيز |
|---|---|
| Benzocaine Hydrochloride | - |
| Resorcinol | - |
المؤشرات العلاجية والاستخدام
الجرعة وطريقة الإعطاء
التحذيرات والاحتياطات
Warnings For external use only Allergy Allert Do not use this product if you have a history of allergy to local anesthetics such as procaine, butacaine, benzocaine or other –caine anesthetics. Avoid contact with eyes in case of contact rinse thoroughly and immediately with water.
Frequently Asked Questions
Uses Temporarily Relieves Itching
Directions Adults and children 12 years and older Apply a finger tip amount (approxiamtely a 1 inch strip) to the affected areas not more than 3 to 4 times daily Children under 12 years ask a doctor
Warnings For external use only Allergy Allert Do not use this product if you have a history of allergy to local anesthetics such as procaine, butacaine, benzocaine or other –caine anesthetics. Avoid contact with eyes in case of contact rinse thoroughly and immediately with water.
20% Benzocaine And 3% Resorcinol Cream is available over the counter (OTC) without a prescription.
Similar Topical Products
Browse all Topical products →References & Data Sources
- • DailyMed — 20% Benzocaine And 3% Resorcinol Cream drug label (National Library of Medicine)
- • openFDA — 20% Benzocaine And 3% Resorcinol Cream label data (U.S. Food & Drug Administration)
- • RxNorm — RXCUI 637518 (NLM Normalized Drug Names)
- • NDC Directory — 20% Benzocaine And 3% Resorcinol Cream (FDA National Drug Code)
إخلاء المسؤولية الطبية
المعلومات الواردة في هذه الصفحة مخصصة للأغراض التعليمية فقط ولا ينبغي استخدامها بديلًا عن المشورة الطبية المتخصصة أو التشخيص أو العلاج.
استشر دائمًا طبيبك أو أي مقدم رعاية صحية مؤهل بشأن أي أسئلة تتعلق بحالة طبية أو دواء.
مصادر البيانات: DailyMed (NLM), openFDA, MFDS